Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sep 14, 2010


High Throughput Genomics has appointed John Wineman to be vice president of new business development for the company's western region, and has hired Thomas Vasicek as vice president of clinical programs and product innovation, the Tucson, Ariz.-based firm said this week.

Prior to joining HTG, Wineman served as director of business development for FEI's life science market division. Before that, he served as director of strategic marketing and director of corporate development for Ventana Medical Systems, now part of Roche. Wineman holds an MBA from San Diego State University and a BS in biology from Oregon State University.

Before joining HTG, Vasicek was senior director of medical innovation for Ventana Medical Systems. He previously served as senior director of bioscience technology development at Medtronic. Vasicek holds a PhD in genetics from Harvard University.

Linda Rubinstein has been named a partner at FLG Partners, a consulting and services firm.

Rubinstein previously was chief financial officer of Solexa. She also served as vice president of finance of ChemoCentryx and senior vice president of Lehman Brothers' Global Healthcare Group. Rubinstein currently sits on the board of directors of Sensorin. She holds a BA and an MA in economics from the University of California, Los Angeles.

WaferGen Biosystems this week appointed Donald Huffman as its new chief financial officer. Huffman recently was CFO at Asante Solutions. Before that, he was CFO at Guava Technologies, now Millipore; EndoSonics, now Volcano; Microcide Pharmaceuticals; Celtrix Pharmaceuticals; and Sanderling Ventures.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.